QQ客服 官方微博 反馈留言

浏览/检索结果: 共19条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma 期刊论文 2019, 卷号: 11, 期号: 1, 页码: 319-328 作者:  Mao, Yousheng;  Yu, Zhentao;  You, Bin;  Fang, Wentao;  Badgwell, Brian 收藏  |  浏览/下载：30/0  |  提交时间：2020/01/03 The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer 期刊论文 2018, 卷号: 10, 期号: 9, 页码: 5538-5544 作者:  Zhou Qinghua;  Dong Jingsi;  He Jie;  Liu Deruo;  Tian David H 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文 2018, 卷号: 4, 期号: 11, 页码: 1569-1575 作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文 2018, 卷号: 122, 页码: 32-37 作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Anlotinib  Non-small cell lung cancer  Quality of life   Society for Translational Medicine Expert Consensus on the preoperative assessment of circulatory and cardiac functions and criteria for the assessment of risk factors in patients with lung cancer 期刊论文 2018, 卷号: 10, 期号: 9, 页码: 5545-5549 作者:  Liu, Deruo;  Wen, Huanshun;  He, Jie;  Gao, Shugeng;  Li, Shanqing 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer 期刊论文 2018, 卷号: 10, 期号: 10, 页码: 5666-5672 作者:  Liu, Lunxu;  Mei, Jiandong;  He, Jie;  Gao, Shugeng;  Li, Shanqing 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery 期刊论文 2018, 卷号: 10, 期号: 5, 页码: 3039-3053 作者:  Li, Hui;  Jiang, Gening;  Bolukbas, Servet;  Chen, Chun;  Chen, Haiquan 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients 期刊论文 2018, 卷号: 10, 期号: 2, 页码: 1050-1057 作者:  Yu, Zhentao;  Li, Shanqing;  Liu, Deruo;  Liu, Lunxu;  He, Jianxing 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文 2018, 卷号: 15, 期号: 4, 页码: 443-451 作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Non-small cell lung cancer  anlotinib  prognostic factor analysis  third- or further-line therapy   Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文 2017, 卷号: 18, 页码: S3-S3 作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03